126 related articles for article (PubMed ID: 16712960)
1. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Zhou R; Zhou Y; Dong JR; He PL; Wan H; Li YC; Yang YF; Zuo JP
J Neuroimmunol; 2006 Jun; 175(1-2):142-51. PubMed ID: 16712960
[TBL] [Abstract][Full Text] [Related]
2. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo.
Zhou R; Zhang F; He PL; Zhou WL; Wu QL; Xu JY; Zhou Y; Tang W; Li XY; Yang YF; Li YC; Zuo JP
Int Immunopharmacol; 2005 Dec; 5(13-14):1895-903. PubMed ID: 16275624
[TBL] [Abstract][Full Text] [Related]
3. (5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling.
Zhou R; Wang JX; Tang W; He PL; Yang YF; Li YC; Li XY; Zuo JP
Acta Pharmacol Sin; 2006 Dec; 27(12):1616-21. PubMed ID: 17112417
[TBL] [Abstract][Full Text] [Related]
4. (5R)-5-hydroxytriptolide attenuated collagen-induced arthritis in DBA/1 mice via suppressing interferon-gamma production and its related signaling.
Zhou R; Tang W; Ren YX; He PL; Zhang F; Shi LP; Fu YF; Li YC; Ono S; Fujiwara H; Yang YF; Zuo JP
J Pharmacol Exp Ther; 2006 Jul; 318(1):35-44. PubMed ID: 16574782
[TBL] [Abstract][Full Text] [Related]
5. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
[TBL] [Abstract][Full Text] [Related]
6. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
[TBL] [Abstract][Full Text] [Related]
7. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Wang Y; Mei Y; Feng D; Xu L
J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
[TBL] [Abstract][Full Text] [Related]
8. Suppression of (5R)-5-hydroxytriptolide (LLDT-8) on allograft rejection in full MHC-mismatched mouse cardiac transplantation.
Tang W; Zhou R; Yang Y; Li YC; Yang YF; Zuo JP
Transplantation; 2006 Mar; 81(6):927-33. PubMed ID: 16570019
[TBL] [Abstract][Full Text] [Related]
9. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
[TBL] [Abstract][Full Text] [Related]
11. (5R)-5-hydroxytriptolide inhibits the immune response of human peripheral blood mononuclear cells.
Zhou R; Tang W; He PL; Yang YF; Li YC; Zuo JP
Int Immunopharmacol; 2009 Jan; 9(1):63-9. PubMed ID: 18952005
[TBL] [Abstract][Full Text] [Related]
12. Protective and therapeutic effect of triptolide in EAE explained by induction of major stress protein HSP70.
van Eden W
J Neuroimmunol; 2009 Dec; 217(1-2):10-1. PubMed ID: 19833397
[No Abstract] [Full Text] [Related]
13. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse.
Iruretagoyena MI; Tobar JA; González PA; Sepúlveda SE; Figueroa CA; Burgos RA; Hancke JL; Kalergis AM
J Pharmacol Exp Ther; 2005 Jan; 312(1):366-72. PubMed ID: 15331658
[TBL] [Abstract][Full Text] [Related]
14. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response.
Wu Y; Wang Y; Zhong C; Li Y; Li X; Sun B
Int Immunopharmacol; 2003 Oct; 3(10-11):1457-65. PubMed ID: 12946442
[TBL] [Abstract][Full Text] [Related]
15. The suppressive effect of triptolide on chronic colitis and TNF-alpha/TNFR2 signal pathway in interleukin-10 deficient mice.
Wei X; Gong J; Zhu J; Wang P; Li N; Zhu W; Li J
Clin Immunol; 2008 Nov; 129(2):211-8. PubMed ID: 18757245
[TBL] [Abstract][Full Text] [Related]
16. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo.
Zhu YN; Zhao WM; Yang YF; Liu QF; Zhou Y; Tian J; Ni J; Fu YF; Zhong XG; Tang W; Zhou R; He PL; Li XY; Zuo JP
J Pharmacol Exp Ther; 2006 Feb; 316(2):662-9. PubMed ID: 16204471
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo.
Wang JX; Tang W; Yang ZS; Wan J; Shi LP; Zhang Y; Zhou R; Ni J; Hou LF; Zhou Y; He PL; Yang YF; Li Y; Zuo JP
Eur J Pharmacol; 2007 Jun; 564(1-3):211-8. PubMed ID: 17349993
[TBL] [Abstract][Full Text] [Related]
18. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
[TBL] [Abstract][Full Text] [Related]
19. Triptolide inhibits the differentiation of Th17 cells and suppresses collagen-induced arthritis.
Wang Y; Jia L; Wu CY
Scand J Immunol; 2008 Oct; 68(4):383-90. PubMed ID: 18782267
[TBL] [Abstract][Full Text] [Related]
20. [Effects of triptolide on T lymphocyte functions in mice].
Pu LX; Zhang TM
Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):76-9. PubMed ID: 2403021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
